Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56
United States Fiscal year ends December CIK 0001819790 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
William J Phd Link
15 Sep 2026
Director
Sold after exercise
66
$80.01
$5.28K
William J Phd Link
15 Sep 2026
Director
Sold after exercise
759
$79.00
$59.96K
William J Phd Link
15 Sep 2026
Director
Sold after exercise
11,675
$78.33
$914.50K

What was left out

Form 4 filings counted 60
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 3
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 292,795
History held since 20 Oct 2020